Fundraising Fox

Neurelis

Encinitas, US · Delaware corporation · 2 known investors

neurelis.com ↗

Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy. It also maintains a proprietary drug delivery and stabilization technology portfolio applicable to proteins, peptides, and small and large molecules.

BiotechHealthtechMedical Devices

Founders & leadership

CC
Craig C. ChamblissCo-founder
CCCraig Chambliss
Craig ChamblissinCEO and Co-founder

Board

DF
David F. HaleBoard director
CG
Cam GarnerBoard director
YZ
Yong ZhangBoard director
KL
Kevin LiinBoard directorManaging Partner at LYZZ Capital

Investors · 2

LYZZ CapitalShanghai
OrbiMedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$219.1M disclosed across 6 rounds · 2015–2021

▶$114.8MraisedMar 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin LiDirector
  • Huaizheng PengDirector
  • Craig C. ChamblissExecutive Officer, Director
  • Stephen CarttDirector
  • Priyanka BelawatDirector
  • David F. HaleDirector
  • George StuartExecutive Officer
Offering amount
$120M
Amount sold
$114.8M
Sales commissions
$2.4M
Placement agents
Aquilo Partners, L.P.
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.1MraisedOct 2020 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig C. ChamblissExecutive Officer, Director
  • Huaizheng PengDirector
  • Kevin LiDirector
  • David F. HaleDirector
  • George StuartExecutive Officer
  • Stephen CarttDirector
  • Priyanka BelawatDirector
Offering amount
$42.1M
Amount sold
$42.1M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.5MraisedNov 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David F. HaleDirector
  • Craig C. ChamblissExecutive Officer, Director
  • Priyanka BelawatDirector
  • Huaizheng PengDirector
  • George StuartExecutive Officer
  • Kevin LiDirector
Offering amount
$40.5M
Amount sold
$40.5M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.2MraisedAug 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin LiDirector
  • George StuartExecutive Officer
  • Yong ZhangDirector
  • David F. HaleDirector
  • Cam L. GarnerDirector
  • Craig C. ChamblissExecutive Officer, Director
  • Priyanka BelawatDirector
Offering amount
$15M
Amount sold
$5.2M
Minimum investment
$50K
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedDec 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yong ZhangDirector
  • Priyanka BelawatDirector
  • Cam GarnerDirector
  • George StuartExecutive Officer
  • Craig C. ChamblissExecutive Officer, Director
  • David F. HaleDirector
  • Kevin LiDirector
Offering amount
$20M
Amount sold
$15M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David F. HaleDirector
  • Cam GarnerDirector
  • Craig C. ChamblissExecutive Officer, Director
  • Yong ZhangDirector
  • Kevin LiDirector
Offering amount
$10M
Amount sold
$1.5M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Neurelis do?
Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy. It also maintains a proprietary drug delivery and stabilization technology portfolio applicable to proteins, peptides, and small and large molecules.
Who founded Neurelis?
Neurelis was founded by Craig C. Chambliss, Craig Chambliss.
Who are Neurelis's investors?
Neurelis's investors include LYZZ Capital, OrbiMed.
How much funding has Neurelis raised?
Neurelis has disclosed $219.1M raised across 6 rounds.
Where is Neurelis headquartered?
Neurelis is headquartered in Encinitas, US.